Marc M. Kurtz - Concepedia

Author

Marc M. Kurtz

Merck & Co., Inc., Rahway, NJ, USA (United States)ORCID

Also Known As

Kurtz, M., Kurtz, M.M., M M Kurtz, M. KURTZ, M. Kurtz, M. M. KURTZ, Marc Kurtz, Marc M Kurtz, Marc M. Kurtz

Publications

Citations

H-Index

Concepts

All Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)MSD (UK) Limited (United Kingdom)Merck (United Kingdom)United States Military Academy

About

Marc M. Kurtz is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, medicine, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	26	1.5K
2	Biochemistry	15	18	1.6K
3	Natural Sciences	9	9	905
4	Health Sciences	1	1	41
5	Cell Biology	1	1	56

Marc M. Kurtz

Publications

Citations

H-Index

Page 1

	Year	Citations
Zaragozic acids: a family of fungal metabolites that are picomolar competitive inhibitors of squalene synthase. James D. Bergstrom, Marc M. Kurtz, Deborah J. Rew, Proceedings of the National Academy of Sciences BiosynthesisNatural Product SynthesisBiochemistrySqualene SynthaseNatural Sciences	1993	334
Systemic pan-AMPK activator MK-8722 improves glucose homeostasis but induces cardiac hypertrophy Robert W. Myers, Hong-Ping Guan, Juliann Ehrhart, Science Cardiac MuscleCardiovascular PharmacologyGlucose HomeostasisMetabolic RemodelingCardiovascular Function	2017	329
Structural Optimization Affording 2-(<i>R</i>)-(1-(<i>R</i>)-3,5-Bis(trifluoromethyl)phenylethoxy)-3-(<i>S</i>)-(4-fluoro)phenyl-4- (3-oxo-1,2,4-triazol-5-yl)methylmorpholine, a Potent, Orally Active, Long-Acting Morpholine Acetal Human NK-1 Receptor Antagonist Jeffrey J. Hale, Sander G. Mills, Malcolm MacCoss, Journal of Medicinal Chemistry Orally ActivePharmacotherapyPharmaceutical ChemistryVascular PermeabilityMolecular Pharmacology	1998	203
Identification, localization and receptor characterization of novel mammalian substance P-like peptides Marc M. Kurtz, Ruiping Wang, Michelle K. Clements, Gene BiochemistryMedicineNatural SciencesProteomicsPeptide Engineering	2002	171
Phosphorylated Morpholine Acetal Human Neurokinin-1 Receptor Antagonists as Water-Soluble Prodrugs Jeffrey J. Hale, Sander G. Mills, Malcolm MacCoss, Journal of Medicinal Chemistry Regioselective DibenzylphosphorylationBiochemistryMedicineLiver PhysiologyWater-soluble Prodrugs	2000	95
2-Aryl Indole NK1 receptor antagonists: optimisation of indole substitution Laura C. Cooper, Gary G. Chicchi, Kevin Dinnell, Bioorganic & Medicinal Chemistry Letters Functional SelectivityMedicineIndole SubstitutionImmunologyReceptor (Biochemistry)	2001	70
Farnesol-derived Dicarboxylic Acids in the Urine of Animals Treated with Zaragozic Acid A or with Farnesol Richard G. Bostedor, John D. Karkas, Byron H. Arison, Journal of Biological Chemistry Animal PhysiologyAnimals TreatedPharmacological StudyBiochemistrySqualene Synthase	1997	67
Cholesterol in human atherosclerotic plaque is a marker for underlying disease state and plaque vulnerability Zhu Chen, Marina Ichetovkin, Marc M. Kurtz, Lipids in Health and Disease	2010	66
The isolation and structure elucidation of zaragozic acid C, a novel potent squalene synthase inhibitor. Claude Dufresne, Kenneth E. Wilson, Deborah L. Zink, Tetrahedron Medicinal ChemistryBiochemistryZaragozic Acid CNatural SciencesBiocatalysis	1992	58
2-Aryl indole NK1 receptor antagonists: optimisation of the 2-Aryl ring and the indole nitrogen substituent Kevin Dinnell, Gary G. Chicchi, Madhumeeta J Dhar, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryIndole Nitrogen SubstituentFunctional SelectivityMedicineImmunology	2001	56

Page 1